cover image: Clopidogrel versus other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention

Premium

20.500.12592/7422sz

Clopidogrel versus other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention

28 Oct 2010

Erin Russell led the research on the economic section, extracted data for the economic review, performed quality assessment of economic studies, wrote the economic review, performed the primary economic analyses, wrote the economic evaluation section, performed the population and budget impact analyses, wrote the population and budget impact sections, and contributed to revisions of the draft. [...] Jafna Cox contributed to the planning of the report, provided direction and clinical insight as required throughout the process, wrote the ethics and psychosocial sections, and critically reviewed the drafts. [...] Mukul Sharma was associated in planning the focus, scope, and operations of the review; commented on analysis and interpretation of data; and critically reviewed and edited the drafts. [...] The results of a review of economic evaluations were used to inform our economic evaluation of clopidogrel plus ASA, ASA alone, and ticlopidine plus ASA for the prevention of vascular events in adult patients undergoing PCI. [...] Economic Review Of the seven economic evaluations that were relevant for inclusion in the literature review, none evaluated the cost-effectiveness of clopidogrel from the perspective of a Canadian provincial ministry of health.
health cost-benefit analysis research medicine cardiovascular disease prescription drugs meta-analysis therapy coronary artery disease stroke acute coronary syndrome clinical trial atherosclerosis clinical medicine blood platelets ticlopidine rcts healthcare policy heart disease health treatment medical drugs coronary stent diseases and conditions peripheral vascular diseases secondary prevention coronary heart disease pci antiplatelet drug clopidogrel percutaneous coronary intervention drug-eluting stent antiplatelet agents platelet aggregation inhibitors hematologic agents atheroma acetylsalicylic acid
Pages
191
Published in
Canada

Related Topics

All